MY117975A - Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists - Google Patents
Substituted imidazoles as dual histamine h1 and h3 agonists or antagonistsInfo
- Publication number
- MY117975A MY117975A MYPI20014365A MYPI20014365A MY117975A MY 117975 A MY117975 A MY 117975A MY PI20014365 A MYPI20014365 A MY PI20014365A MY PI20014365 A MYPI20014365 A MY PI20014365A MY 117975 A MY117975 A MY 117975A
- Authority
- MY
- Malaysia
- Prior art keywords
- agonists
- antagonists
- substituted imidazoles
- dual histamine
- well
- Prior art date
Links
- 230000009977 dual effect Effects 0.000 title abstract 2
- 150000002460 imidazoles Chemical class 0.000 title abstract 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 title 2
- 239000000556 agonist Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 229960001340 histamine Drugs 0.000 title 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000938 histamine H1 antagonist Substances 0.000 abstract 1
- 239000003395 histamine H3 receptor antagonist Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23405300P | 2000-09-20 | 2000-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY117975A true MY117975A (en) | 2004-08-30 |
Family
ID=22879692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20014365A MY117975A (en) | 2000-09-20 | 2001-09-18 | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6506756B2 (enExample) |
| EP (1) | EP1318994B1 (enExample) |
| JP (1) | JP2004509871A (enExample) |
| CN (1) | CN1461303A (enExample) |
| AR (1) | AR030946A1 (enExample) |
| AT (1) | ATE387439T1 (enExample) |
| AU (1) | AU2001292730A1 (enExample) |
| CA (1) | CA2421826C (enExample) |
| DE (1) | DE60133014T2 (enExample) |
| ES (1) | ES2300364T3 (enExample) |
| HK (1) | HK1052179A1 (enExample) |
| MX (1) | MXPA03002448A (enExample) |
| MY (1) | MY117975A (enExample) |
| TW (1) | TW589303B (enExample) |
| WO (1) | WO2002024659A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6607862B2 (en) | 2001-08-24 | 2003-08-19 | Intel Corporation | Damascene extreme ultraviolet lithography alternative phase shift photomask and method of making |
| RU2323935C2 (ru) * | 2002-04-18 | 2008-05-10 | Шеринг Корпорейшн | Производные бензимидазола, их применение и фармацевтическая композиция на их основе, обладающая свойствами антагониста рецептора гистамина h3 |
| CN100360130C (zh) * | 2002-04-18 | 2008-01-09 | 先灵公司 | 用作组胺h3拮抗剂的1－(4－哌啶基)苯并咪唑酮 |
| US7105505B2 (en) | 2002-04-18 | 2006-09-12 | Schering Corporation | Benzimidazole derivatives useful as histamine H3 antagonists |
| NL1026634C2 (nl) * | 2004-07-12 | 2006-01-16 | Willem Jacob Van Der Burg | Psychofarmaceutisch preparaat en werkzame stof daarin. |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| US9224955B1 (en) * | 2014-10-31 | 2015-12-29 | Feng-wen Yen | Purifying method for organic optoelectronic material |
| CN113880808B (zh) * | 2020-07-03 | 2024-12-31 | 合肥医工医药股份有限公司 | 一类三唑类化合物、制备方法及其医药用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2586562B1 (fr) | 1985-09-02 | 1989-03-10 | Inst Nat Sante Rech Med | Composition pharmaceutique contenant de l'a-methylhistamine |
| JPH0678315B2 (ja) * | 1988-04-28 | 1994-10-05 | シェリング・コーポレーション | 新規なベンゾピリド‐ピペリジン、ピペリジリデンおよびピペラジン化合物、組成物、製造法および利用法 |
| GB8916947D0 (en) | 1989-07-25 | 1989-09-13 | Smith Kline French Lab | Medicaments |
| EP0448765B1 (de) | 1990-03-30 | 1994-08-17 | HEUMANN PHARMA GMBH & CO | Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung |
| GB9115740D0 (en) | 1991-07-20 | 1991-09-04 | Smithkline Beecham Plc | Medicaments |
| AU662588B2 (en) | 1991-12-18 | 1995-09-07 | Schering Corporation | Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine H3 agonists/antagonists |
| US5352707A (en) | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
| NZ276883A (en) | 1993-11-15 | 1998-08-26 | Schering Corp | 1h-imidazol-4-yl)alkyl]benzene derivatives |
| FR2732017B1 (fr) | 1995-03-21 | 2000-09-22 | Inst Nat Sante Rech Med | Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques |
| PT1019050E (pt) | 1997-06-24 | 2002-09-30 | Novo Nordisk As | Utilizacao de agonisticos e de antagonisticos de somatostatina para o tratamento de doencas associadas ao olho |
| US5869479A (en) | 1997-08-14 | 1999-02-09 | Schering Corporation | Treatment of upper airway allergic responses |
| WO2000005215A1 (en) | 1998-07-24 | 2000-02-03 | Russinsky Limited | A process for preparing benzocycloheptapyridin-11-ones |
-
2001
- 2001-09-18 MX MXPA03002448A patent/MXPA03002448A/es active IP Right Grant
- 2001-09-18 CA CA002421826A patent/CA2421826C/en not_active Expired - Fee Related
- 2001-09-18 EP EP01973119A patent/EP1318994B1/en not_active Expired - Lifetime
- 2001-09-18 CN CN01815978A patent/CN1461303A/zh active Pending
- 2001-09-18 JP JP2002529071A patent/JP2004509871A/ja not_active Withdrawn
- 2001-09-18 US US09/954,867 patent/US6506756B2/en not_active Expired - Fee Related
- 2001-09-18 WO PCT/US2001/029095 patent/WO2002024659A2/en not_active Ceased
- 2001-09-18 HK HK03104436.1A patent/HK1052179A1/zh unknown
- 2001-09-18 MY MYPI20014365A patent/MY117975A/en unknown
- 2001-09-18 AR ARP010104399A patent/AR030946A1/es unknown
- 2001-09-18 AU AU2001292730A patent/AU2001292730A1/en not_active Abandoned
- 2001-09-18 DE DE60133014T patent/DE60133014T2/de not_active Expired - Lifetime
- 2001-09-18 ES ES01973119T patent/ES2300364T3/es not_active Expired - Lifetime
- 2001-09-18 AT AT01973119T patent/ATE387439T1/de not_active IP Right Cessation
- 2001-09-19 TW TW090123001A patent/TW589303B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2421826C (en) | 2009-10-27 |
| AU2001292730A1 (en) | 2002-04-02 |
| DE60133014T2 (de) | 2009-02-26 |
| ES2300364T3 (es) | 2008-06-16 |
| US6506756B2 (en) | 2003-01-14 |
| EP1318994B1 (en) | 2008-02-27 |
| HK1052179A1 (zh) | 2003-09-05 |
| WO2002024659A3 (en) | 2002-10-24 |
| MXPA03002448A (es) | 2003-06-19 |
| ATE387439T1 (de) | 2008-03-15 |
| US20020086859A1 (en) | 2002-07-04 |
| DE60133014D1 (de) | 2008-04-10 |
| JP2004509871A (ja) | 2004-04-02 |
| WO2002024659A2 (en) | 2002-03-28 |
| CN1461303A (zh) | 2003-12-10 |
| CA2421826A1 (en) | 2002-03-28 |
| TW589303B (en) | 2004-06-01 |
| AR030946A1 (es) | 2003-09-03 |
| EP1318994A2 (en) | 2003-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02005602A (es) | Compuestos de urea que tienen actividad antagonista para el receptor muscarinico. | |
| WO2004087649A3 (en) | Benodiazepine spirohydantoin cgrp receptor antagonists | |
| MY161834A (en) | Substituted diazepan compounds as orexin receptor antagonists | |
| JO2355B1 (en) | Hereditary calcitonin polypeptide receptor antagonists | |
| IL184932A0 (en) | Glucagon receptor antagonists, preperation and therapeutic uses | |
| ATE384050T1 (de) | Benzazepinderivate als histamin-h3-antagonisten | |
| MXPA04000707A (es) | Nuevos antagonistas del receptor y5 del neuropeptido y referencia cruzada a solicitudes relacionadas. | |
| WO2004082602A3 (en) | Carboxamide spirohydantoin cgrp receptor antagonists | |
| MXPA05010859A (es) | Antagonistas mchr1 heterociclicos. | |
| MXPA02005596A (es) | Derivados de carbamato con actividad antagonista para el rerceptor muscarinico. | |
| WO2008021851A3 (en) | Novel compounds as antagonists or inverse agonists for opioid receptors | |
| DK1377586T3 (da) | Tricykliske diazepiner som tocolytiske oxytocinreceptorantagonister | |
| UA100974C2 (ru) | Соединения замещенных диазепанов как антагонисты орексиновых рецепторов | |
| UA86621C2 (ru) | Антагонисты рецептора глюкагона, их получение и терапевтическое применение | |
| SI1957484T1 (sl) | Antagonisti glukagonskega receptorja, priprava in terapevtske uporabe | |
| DE69922528D1 (de) | N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten | |
| EP1398029A8 (en) | NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives | |
| WO2005060959A8 (en) | Pyrazole derivatives and use thereof as orexin receptor antagonists | |
| WO2005082893A3 (en) | Histamine h3 receptor antagonists, preparation and therapeutic uses | |
| WO2002044141A3 (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
| PT1673354E (pt) | Arilindenopiridinas e arilindenopirimidinas e sua utilização como antagonistas do receptor da adenosina a2a | |
| HK1052179A1 (zh) | 作为双重组胺h1和h3激动剂或拮抗剂的取代咪唑 | |
| MY129677A (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
| MY120281A (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
| WO2004026837A3 (en) | Histamine h3 receptor antagonists, preparaton and therapeutic uses |